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This study was undertaken to investigate the possible rela
tionship of Extra-High Frequency (EHF) pure tone thresholds to
the use of oral contraceptives.
The procedure involved the de
termination of auditory thresholds of 42 subjects for the fre
quencies lOK, 12K, 14K, 16K, and 18K Hz using automatic audio
metry.
The subjects were divided into three groups as follows:
(1) 14 women aged 18-28 years who have used oral contraceptives
continuously for the last four or more years; (2) 14 women aged
18-28 years who have used oral contraceptives continuously for
the last one-three years; (3) 14 women aged 18-28 years who have
never used oral contraceptives.
All subjects reported no history
of excessive noise exposure and were required to pass a pure tone
screening test bilaterally for the frequencies 2K, 4K, and 6K Hz.
In addition, subjects were controlled for
(a) smoking, (b) m e d 
ically restrictive diets such as low cholesterol or low sugar,
(c) reported elevated blood pressure, and (d) ototoxic drug
usage.
The results of the study indicated no significant differences
in EHF pure tone thresholds between subjects using oral contra
ceptives and control subjects for any of the five Extra-High
Frequencies tested.
There was a general but statistically n o n 
significant trend for the group of women using oral contracep
tives for the last four or more years to have higher mean EHF
thresholds than the group of women using oral contraceptives
for the last one-three years; however, neither group of oral
contraceptive users demonstrated consistently higher EHF thres
holds than the control group.
The differences in results between
this study and previous investigations of the relationship of
EHF thresholds to elevated blood lipids and various blood clot
ting components were discussed in terms of the differences in
subject selection and experimental procedures.
It was concluded
that the use of oral contraceptives does not appear to signifi
cantly affect, as a group, the EHF hearing acuity of normal
women aged 18-28 years.
Suggestions were made concerning p o s 
sible future investigations of the relationship of EHF thres
holds to the use of oral contraceptives.

ii

ACKNOWLEDGMENTS

The author wishes to extend his gratitude to the members of
his thesis committee. Dr.

Charles Parker, Dr. Richard B o e hmler,

Dr. Ralph Leonard, Ms. Barbara Bain, and Dr. Frank Pettinato for
their helpful comments and suggestions.

A special thanks is due

to Dr. Parker, whose firm guidance and genuine interest in this
project served as a major source of motivation.

A special thanks

is also extended to Dr. Leonard for his personal support and
encouragement.

The writer thanks the women who volunteered to

serve as subjects for this study, and especially thanks Chris
Switzer, Ginny Rupp, Joanne Dillon, Kathy Tate, Kathy Stephani,
Joyce Scott, and Katie Murphy for their assistance in obtaining
subjects.

Finally,

the writer wishes to thank his wife and

friend Lynne Giacomino Dugolenski, for the many hours she spent
typing the various drafts of this manuscript, and more importantly
for her support and understanding.

iii

TABLE OF CONTENTS
Page
ABSTRACT ........................................................

il

ACKNOWLEDGMENTS ................................................

iii

LIST OF TABLES

..................................................

LIST OF FIGURES ....................

v
vi

Chapter
I

INTRODUCTION ...........................................

1

II

PROCEDURE ...............................................

31

III

RESULTS .................................................

36

IV

DISCUSSION ..............................................

47

SUMMARY AND CONCLUSIONS

................................

54

................................................

56

A P P E N D I X ........................................................

61

V

BIBLIOGRAPHY

iv

LIST OF TABLES

Table

Page

1

Group Means and Standard Deviations for A g e ........

37

2

Means and Standard Deviations for EHF Hearing
Thresholds by Frequency, Ear Tested, and
Duration of Use of Oral Contraceptives ..........

38

Summary of Analysis of Variance of EHF
Thresholds at lOK Hz ...............................

39

Summary of Analysis of Variance of EHF
Thresholds at 12K Hz ...............................

40

Summary of Analysis of Variance of EHF
Thresholds
at 14K Hz ...............................

41

Summary of Analysis of Variance of EHF
Thresholds
at 16K Hz ...............................

42

Summary of Analysis of Variance of EHF
Thresholds
at 18K Hz ...............................

43

Summary of F-Tests Comparing Group Variances
by Ear Tested and Frequency .......................

44

3

3„

3

3^

3p

4

LIST OF FIGURES

Figure

Page

Schematic Diagram of the Arterial System
Serving the Human Cochlea .............
Schematic Diagram of a Transverse Section of
the Guinea Pig Spiral L a m i n a ...............

VI

CHAPTER 1

INTRODUCTION

In recent years there has been a growing interest in the
relationship between cardiovascular problems and the auditory
system.

More specifically, several authors have attempted to

demonstrate elevated pure tone thresholds for subjects who suffer
from cardiovascular disorders.

Researchers using Extra-High

Frequency (EHF) pure tone testing have had some success in demon
strating such a relationship.

The EHF frequencies typically used

in these studies include lOK, 12K, 14K, 16K, and 18K Hertz.
Rosen and Olin (1965) hypothesized that elevated thresholds for
these frequencies may reflect a process of vascular pathology that
may eventually lead to arteriosclerosis and coronary disease.
The use of EHF pure tone testing may therefore be valuable in
the early detection of cardiovascular disorders.
There are several factors in modern day life that contri
bute to the development of cardiovascular disease.
these factors are tension, diet,
etc.

Included among

lack of exercise, drug usage,

One possible factor that has received a great deal of study

in recent years is the use of oral contraceptives.

The literature

concerning the effects of oral contraceptives on the cardiovas
cular system is in many cases contradictory and inconclusive.

There are, however, several studies that demonstrate blood chem
istry changes associated with cardiovascular disease in users of
oral contraceptives.

If such changes are produced by oral con

traceptives, they may be manifested by elevated thresholds for
the EHF frequencies.

Review of the Literature

Vascular Anatomy of the Cochlea

In order to understand how cardiovascular disorders might
affect the auditory system, it is necessary to have at least a
basic knowledge of the vascular anatomy and physiology of the
inner ear.
Fisch (Knight, 1970) discussed the auditory system in terms
of its vulnerability to vascular changes.

He described the com

plex vascular arrangement of the inner ear as an indication of
high metabolic activity in the auditory system.

Fisch pointed

out that systems of high metabolic activity are susceptible to even
minor vascular changes.

The author stated that the basal end of

the cochlea is the area of highest inner ear metabolic activity and
is therefore the portion most susceptible to vascular interruption.
Finally, he stated that the blood flow through the extremely small
arteries of the inner ear is more easily blocked or impaired than
in larger vessels found in other systems of the body.
Axelsson (1968) provided an excellent description of the
vascular anatomy of the human cochlea (see Figures 1 and 2).

FIGURE I
SCHEMATIC DIAGRAM OF THE ARTERIAL SYSTEM
SERVING THE HUMAN COCHLEA^
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Redrawn from Axelsson, 1968.

FIGURE 2
SCHEMATIC DIAGRAM OF A TRANSVERSE SECTICW
OF THE GUINEA PIG SPIRAL LAMINA^
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Redrawn from Axelsson, 1968.

SPIRAL MODIOLAR ARTERY

The only direct source of blood supply for the inner ear is the
internal auditory artery.
tory artery is as follows:

The derivation of the internal audi
Vertebral Artery ------ *■ Basilar Artery

------ Anterior-Inferior Cerebellar Artery -----Artery.

*■

Internal Auditory

As the internal auditory artery enters the cochlea,

it

divides into the anterior vestibular artery and the common coch
lear artery.

The common cochlear artery further divides into the

vestibulocochlear artery and the cochlear artery.

The vesti

bulocochlear artery also branches into the vestibular and coch
lear divisions.

The vestibular branch supplies the basal end of the

cochlea, while the cochlear branch supplies the middle and
apical turns (Axelsson,

1968).

Several authors have stated that the susceptibility of the
auditory system to even minor vascular changes is due to the fact
that the cochlear arterioles are end arteries of only a single
vessel (the internal auditory artery).

Hallberg (1975) stated

that these end arteries may be among the first to demonstrate
early symptoms of atherosclerosis.

Fowler

(1959) pointed out

that the arterioles of the Organ of Corti are terminal,

and are

therefore particularly susceptible to agglutination and clotting.
Polus (1972) stated that since the inner ear is dependent on
only one artery for its blood supply, any change,

spasm, embolism,

or thrombosis that may inhibit the function of this artery may
also produce changes in the cochlea.

Johnsson and Hawkins

(1972)

suggested that a decrease in blood flow through the internal
auditory artery can lead to anoxia and eventually to degeneration
of the walls of those vessels that are supplied by it.
While there is general agreement in the literature concern
ing the anatomical vulnerability of the auditory system to vascular
changes, there is some disagreement as to whether the vascular
anatomy of the cochlea creates a particular susceptibility of
the basal end of the cochlea.

Axelsson (1968) found the following

two characteristics of the auditory vascular system in 60 cada
vers:

(1)

the breadth of the stria vascularis decreased progres

sively from basal to apical end;

(2) there was a marked reduction

of the number of arterio-venous anastomoses external to the
stria vascularis in going from the basal to the apical end.
Axelsson suggested that the reduced number of anastomoses at the
apical end of the cochlea allows for fewer possibilities for
adjustment in the event of circulation changes.

The basal end,

with its greater number of anastomoses, should have more available
pathways for shunting blood around portions of the capillary n e t 
work that may be damaged.

The author's conclusion is that the v a s 

cular anatomy of the cochlea does not appear to create a higher
vulnerability for the basal end to vascular disorders as compared
to the apical end.
Falbe-Hansen and Thomsen

(1963), on the other hand,

suggested

that the vascular anatomy of the basal turn of the cochlea does

indeed make it particularly susceptible to circulatory defects.
They stated that the degree of development and complexity of the
stria vascularis at the basal end may indicate that this region
has the highest oxygen requirements.

Thus any condition that

reduces the oxygen delivery to the cochlea,

such as partial or

total blockage of the internal auditory artery or its branches,
may produce the greatest damage at the basal end.
Other authors have suggested that the blood supply of the
stria vascularis is not the crucial source of nutrients for main
taining the inner ear hair cells.

Lawrence (1966)

stated that

there are three capillary areas around the scala media that may
serve to provide nutrients for the Organ of Corti:
vascularis;

(2) spiral prominence;

(3) vas spirale.

(1) stria
His study

with 15 guinea pigs indicated that occlusion of the vas spirale
resulted in a loss of cochlear hair c e l l s , even when the stria
vascularis and spiral prominence capillaries were intact.

On

the other hand, occlusion of only the stria vascularis network
did not result in hair cell degeneration.

Lawrence

(1970) suggested

that the vas spirale is responsible for nourishing the Organ of
Corti, while the stria vascularis maintains the electrolytic
balance within the endolymph.
Kirikae et al.

(1969) provided a detailed description of

the spiral lamina vascular system as found in 18 human temporal
bone sections.

The vas spirale is a looping capillary vessel that
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lies below the tunnel of Corti.

The length of the loops vary from

turn to turn, and the apical end of this vessel has more branching
and anastomoses than the basal end.

The authors stated that the

capillary density of the 500 Hz area of the vas spirale is 1.5
times greater than the capillary density of the 8K Hz area.
Kirikae et al.

(1969) also described a second spiral vessel

system that runs along the inner hair cells of the cochlea.
This vessel is well separated from the vas spirale at the basal
end, but lies near the vas spirale at the apical end.

This situa

tion also favors the apical end in the event of circulatory
disturbances; if the vas spirale fails to function due to vascular
occlusion, the other spiral vessel can help compensate for the
resulting loss of blood supply to the cells of the apical end to
a much greater degree than those at the basal end.
Johnsson and Hawkins (1972) also described the outer spiral
vessel as having fewer radiating capillaries as tributaries in the
basal turn than in the middle and apical turns.

If the vas

spirale is indeed the source of nutrients for the Organ of Corti,
the fewer capillaries and anastomoses at the basal end makes that
portion of the cochlea more susceptible to damage from vascular
pathology than the apical end.

The Relationship of Hearing Loss and Cardiovascular Disorders
Vascular pathology has been suggested as the cause of
several forms of auditory pathology, including Meniere's disease

(Davis and Silverman, 1970), noise induced hearing loss (Hawkins,
1971), drug ototoxicity (Lawrence, 1970), presbycusis (Fowler, 1959;
Johnsson and Hawkins, 1972a, 1972b), and sudden deafness
1957; Altshuler and Welsh,

(Hallberg,

1966; Jaffe, 1967, 1968, 1970; Polus,

1972; and Saunders, 1972).
Still another area of investigation is the relationship of
hearing loss with cardiovascular disease and/or the physiological
conditions associated with it.

Certain studies have not succeeded

in demonstrating such a relationship.

Hopkinson and Lindberg

(1971) obtained pure tone thresholds for the frequencies 250-8K
Hz on four subjects suffering from hypertension.

The thresholds

obtained were not found to be significantly elevated, although
the small number of subjects used reduced the power of this study.
Hansen (1968) studied 342 hypertensive patients over 45 years of
age.

After eliminating those subjects with a history of noise

exposure, the author found no significant differences between the
pure tone thresholds of patients with normal blood pressure,
slightly elevated blood pressure, and significantly elevated blood
pressure.
Ismail et al.

(1973) investigated the pure tone thresholds

of 64 subjects aged 23-62 years.

The experimental group consisted

of 54 subjects who participated in an exercise program three times/
week for eight months.

The control group consisted of ten subjects

who did not participate in the exercise program.

The exercise

program produced physiological conditions that are not conducive
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to cardiovascular disease, such as a lowered resting heart rate,
increased maximal oxygen intake, lowered submaximal heart rate,
etc.

Pure tone thresholds for the frequencies 2K, 4K, 6K, 8K, lOK,

12K, and 14K Hz were obtained on all subjects before and after
the exercise program was instituted.

The authors found no sig

nificant differences in thresholds between the experimental and
control group for any of the frequencies tested.

It should be

noted that the exercise program did not reduce all the factors
commonly associated with cardiovascular disease,
cholesterol and glucose levels.

such as serum

Another important consideration

is that most of the subjects did not demonstrate abnormal car
diovascular conditions before the exercise program was initiated;
it may be that the auditory system is affected only by abnormal
physiological conditions associated with cardiovascular disease.
Drettner et al.

(1975) investigated the relationship of pure

tone thresholds with several different factors that may be present
with cardiovascular disorders.

The factors studied included

systolic blood pressure, diastolic blood pressure, heart rate,
serum cholesterol, serum triglycerides, uric acid, hematocrit,
glucose tolerance, smoking habits, and noise exposure.

The sub

jects consisted of 762 men 50 years of age, all of whom demon
strated at least one of the factors above.

Pure tone thresholds

were obtained bilaterally for the frequencies 500, IK, 2K, 3K, 4K,
and 6K Hz.

The authors found no significant correlations be-
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tween hearing loss and cardiovascular risk factors, with the
exception of smoking habits.

It was discovered that those sub

jects who had smoked for 10 years or more and who were currently
smoking more than 10 cigarettes/day had poorer pure tone thresholds
for the right ear than the subjects who did not smoke.

The authors

could not account for this selection difference for the right ear
only.
While the studies cited above failed to demonstrate a rela
tionship between hearing loss and physiological conditions character
istic of cardiovascular disease, the current literature contains a
number of studies that suggest such a relationship.

Hopkinson

and Lindberg (1971) found mild high frequency sensorineural hearing
losses for the frequencies 250-8K Hz in six patients suffering
from atherosclerosis.

The authors admitted, however, that these

hearing losses could be the result of other factors such as en
vironmental noise or presbycusis.
Jaffe

(1970) conducted a five year study involving 40 patients

who suffered from sudden hearing loss.

He found that 11 of the

40 patients had demonstrated a pathological acceleration of blood
coagulation after the sudden onset of hearing loss.

Histologic

investigation of one of these subjects who had died revealed intravascular clots in vessels of the spiral ligament and stria vas c u 
laris.
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Rosen (1962) conducted a study of 541 members of the
primitive Mabaan tribe in the Sudan.

The subjects ranged in age from

19-90+ years, and pure tone thresholds were obtained for each sub
ject for the frequencies 500-6K Hz.

The results indicated that

unlike modern Western society, the Mabaans did not acquire poorer
pure tone thresholds for the high frequencies with aging.

Rosen

noted that this population is virtually free from high blood pressure,
coronary thrombosis, ulcers, and other pathological conditions
that frequently occur with aging in our own culture.

Rosen con

cluded that high blood pressure and atherosclerosis of small blood
vessels of the inner ear may contribute at least in part to the
progressive hearing loss characteristic of presbycusis.

He does

admit, however, that the superior hearing acuity of the Mabaans
as compared to our own society may be attributable to other fac
tors such as climate, racial differences, genetic factors, or the
relatively noise free environment of the Mabaan tribe.
Rosen et al.

(1964) continued their study of this tribe

by obtaining pure tone thresholds for the frequencies 12K-24K Hz
on at least 100 subjects in each decade between the ages of 10-70
years.

The authors conducted the same testing on at least 100

subjects in every decade between 10-70 years in the cities of N e w
York, Düsseldorf, and Cairo.

The results indicated superior

hearing for these frequencies among the Mabaan tribe as compared
to the subjects found in the three cities.

This superiority was

evident for all age decades, but particularly for the age decades
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30-39 and older.

The authors suggest that the lack of hypertension,

atherosclerosis, or noise, and other environmental and genetic
factors present in this tribe may all be factors related to their
superior hearing acuity.
Rosen et al.

(1970b) conducted another epidemiological

study in the U . S . S . R . , where they compared the pure tone thresholds
of subjects from two different locations that have characteristically
different diet habits.
as follows:

The two groups of subjects were divided

(1) 235 clerical and factory workers aged 40-59 years

from Moscow, where the diet is characterized by high levels of
saturated fats and carbohydrates, and the incidence of athero
sclerosis and coronary heart disease is also high;

(2) 188 clerical

and factory workers aged 40-59 years from the Georgian Soviet
Republic, where the diet typically is low in saturated fats and
the incidence of coronary heart disease is also low.

The authors

hypothesized that a diet containing high levels of saturated fat
disturbs blood lipid balance and may accelerate the development of
atherosclerosis.

This in turn may lead to occlusion of the

tiny cochlear blood vessels, resulting in elevated pure tone
thresholds.
The results indicated significantly better hearing for
the Georgian subjects, and at 4K Hz the Georgian factory workers had
better pure tone thresholds than the Moscow clerical workers.
The authors suggested that this finding indicates that the dif-
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ferences in thresholds are primarily due to diet factors and not
to the amount of noise exposure.
The three studies by Rosen et al. cited above would be more
conclusive if the authors had actually demonstrated abnormal blood
lipid levels for their subjects that exhibited elevated pure tone
thresholds.

Although the diets maintained by these subjects are

characterized by high levels of saturated fats, there is no evidence
presented that demonstrated pathological vascular changes such as
elevated blood lipids.

Thus it is difficult to determine if the

elevated thresholds are really due to the differences in diet
between the two groups.
In an attempt to demonstrate more conclusively the rela
tionship of elevated pure tone thresholds and high fat diets,
Rosen and Olin (1965) conducted a study of patients in two mental
institutions in Finland.

The typical Finnish diet is high in

saturated fats, and the country has one of the highest incidence
rates in the world for coronary disease.

The subjects for this

study consisted of two groups from each hospital as follows:

(1)

Experimental hospital— one group of 39 subjects aged 40-49 years, and
another group of 97 subjects aged 50-59 years;

(2) Control hospital—

one group of 37 subjects aged 40-49 years, and another group of
106 subjects aged 50-59 years.

The experimental groups were

maintained on a diet in which all milk fat was replaced by soybean
oil, while the control groups maintained the typical Finnish diet.
These dietary conditions were controlled for a period of five years.
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resulting in decreases of mean serum cholesterol levels and blood
coagulability for both experimental groups.

Pure tone thresholds

were obtained from all subjects for the frequencies 500-4K Hz and
12K-24K Hz.

The results indicated that the patients from the

experimental hospital had better pure tone thresholds for all
frequencies;

for the frequencies 500-4K Hz and 12K-24K Hz the

thresholds of the experimental patients aged 50-59 years were as
good as, or better than, the thresholds of the control subjects
aged 40-49 years.

The frequency of response to the frequencies

12K-24K Hz was higher for both experimental groups as compared
to the corresponding age groups in the control hospital.

The

authors concluded that the differences in hearing thresholds may
parallel the differences in saturated fat content of the diets
employed.

A major flaw in this study, however, is the absence of

pure tone thresholds for the subjects before the experimental diet
was introduced;

it is possible that the experimental groups were

superior to the control groups in hearing acuity even before the
change in diet began.
Rosen et al.

(1970a) continued their study of these sub

jects by reversing the diets employed for a period of 3-1/2 years.
Hospital N, originally on the soybean oil diet, returned to the
typical Finnish diet, while Hospital K, originally on the typical
Finnish diet, was now placed on the soybean oil diet.
3-1/2 year period,

After the

the subjects from Hospital K had mean serum

cholesterol levels 35-40 mg/100 m l lower than the serum cholesterol
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levels of subjects from Hospital N,

The authors were able to

conduct audiometric testing on 90 of the original subjects from
Hospital N and 75 of the original subjects from Hospital K.
The results in comparison to those obtained in the 1966 study in
dicated that the thresholds at 500-6K Hz for the age group aged
40-49 years were elevated for Hospital N, while the thresholds
for the same age group in Hospital K demonstrated improvement.

In

neither case, however, were these changes in threshold statis
tically significant.

The subjects of Hospital N aged 50-59 years

demonstrated significant elevation of thresholds for the fre
quencies IK, 2K, and 4K Hz, while the subjects of the same age
from Hospital K demonstrated significant improvements in thresholds
for the frequencies 500 and 2K Hz.
The results from the EHF (12K-24K Hz) testing of the two
groups aged 40-49 years in comparison to the 1964 results indicated
a significant elevation of thresholds for 12K Hz and a drop in the
frequency of response for the other Extra-High frequencies in
subjects from Hospital N, while the thresholds in subjects from
Hospital K demonstrated significant improvement at 12K Hz, with
no change in frequency of response for the other Extra-High
frequencies.

There were no significant changes in thresholds

for these frequencies in either of the 50-59 year groups, as the
frequency of response for Extra-High frequencies by these groups
was very low.

17

Based on the results of their study of the two mental in
stitutions, Rosen and Olin (1965) hypothesized that a young popula
tion from an area with a high incidence of coronary disease should
have poorer pure tone thresholds for the frequencies 12K-2AK Hz
than a similar aged population from an area with a low incidence
of coronary disease.

To test this hypothesis, the authors con

ducted a study of 42 East Finns aged 19-29, and a similar aged
group of 68 Yugoslavs.

As noted previously, the Finns are noted

for having a high mean serum cholesterol level (297 mg/lOOml)
and incidence of coronary heart disease; the Yugoslavs' on the
other hand, have a much lower mean serum cholesterol level (183mg/
100ml) and

one of the lowest incidence rates

disease in

all of Europe.

of coronary heart

The results indicated that the Yugo

slavs had significantly superior hearing for the frequencies
14K and 16K Hz, particularly when comparing those subjects aged
20-29 years.

The authors suggested that these differences may be

a reflection of the initial stages of a developing vascular path
ology.

As

in the previous studies cited, it

is difficult to de

termine if

the differences in thresholds are

truly a reflection

of differences in dietary habits or if they are due to some other
factor(s).
Some authors have conducted studies that relate hearing loss
to clinically diagnosed blood chemistry symptoms that are often
associated with cardiovascular disease.

Spencer (1973) performed
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blood analyses on 300 subjects diagnosed as having inner ear
disease.

He defined inner ear disease as including hearing

loss, tinnitus, and occasional vertigo.

Of these 300 subjects,

42.33% had clearly defined hyperlipoproteinemia (HLP), and another
8.66% were diagnosed as having borderline HLP.

Spencer defined

hyperlipoproteinemia as including any of the following:

elevated

plasma cholesterol levels; elevated serum lipoproteins; and ele
vated serum triglycerides.

The author pointed out that the in

cidence of HLP in the normal population is 15-20%, while the in
cidence for his experimental subjects is 51%.

He concluded that

hearing loss may be associated with elevated levels of serum
cholesterol, triglycerides, and/or other blood components.

He

also noted that HLP has been associated with an increased risk of
coronary heart disease, and he stated that hearing loss may occur
with the early development of such disorders.
Cunningham and Goetzinger

(1974) conducted a study to deter

mine if Extra-High Frequency (EHF) thresholds can serve as pre
dictive measures of hyperlipidemia and the development of early
atherosclerosis.

The authors stated that although blood tests can

identify hyperlipidemia,
ischemic changes.

they do not provide objective evidence of

EHF thresholds may be one way of demonstrating

such changes.
The study involved 20 hyperlipidémie subjects (serum
cholesterol > 350mg/100ml and triglycerides > 140mg/100ml) and 20
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control subjects.

All subjects were aged 20-50 years, had no history

of noise exposure, were otologically normal, and passed a pure tone
screening test of 20dB for IK and 2K Hz, and 35dB for 4K and 6K Hz.
The results indicated modest, but significant differences in pure
tone thresholds for the frequencies 10K-18K Hz.

The differences

were particularly evident for 14K Hz, and the thresholds for the
right ear were more discriminating between the two groups than
left ear thresholds.

The authors concluded that EHF hearing acuity

may act as a monitor of the atherosclerotic process as manifested
in small arteries.
Podoshin et al.

(1975) obtained pure tone audiograms for the

frequencies 250-8K Hz on 59 subjects aged 41-59 years who had
suffered myocardial infarction within the three years prior to the
study.

The control group consisted of 29 subjects of normal health

who were matched with the experimental group for age.

The authors

controlled for those factors that could affect hearing acuity,
such as family history of hearing loss, noise exposure, and drug
usage.

Normal hearing was defined as pure tone thresholds of 30dB

or better for all frequencies tested.

The results indicated that

59.6% of the control subjects had normal hearing, while only 42.3%
of the experimental subjects met the normal hearing criteria.
The authors also found that those subjects with blood sugar levels
above 120mg/100ml had elevated pure tone thresholds compared to
those subjects with normal blood sugar levels.

The authors con

cluded from this data that the hearing loss frequently seen in the
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diabetic patient may be a manifestation of an atherosclerotic
process.
Although the experimental designs of several of the studies
cited above demonstrate certain weaknesses,

there appears to be

adequate evidence that the auditory system does reflect certain
physiological symptoms often associated with cardiovascular
changes.

Physiological Symptoms of Cardiovascular Disease Associated With
the Use of Oral Contraceptives
One factor that may contribute to the development of physio
logical symptoms associated with cardiovascular disorders is the
use of oral contraceptives, although the literature concerning
the effects of oral contraceptives on the vascular system contains
many contradictions.

H a m and Rose (1969) stated that the contra

dictory results found in various studies may be due to different
techniques and experimental designs used to assess the effects of
oral contraceptives on the vascular system.

There are, however,

certain vascular effects of oral contraceptives that have been
confirmed by several authors.

Fletcher and Alkjaersig (Salhanick

et a l . , 1969) suggested two alternative hypotheses relating the
use of oral contraceptives to the development of symptoms of cardio
vascular disease;

(1) contraceptive agents induce in all, or a

majority of users, some chemical alterations leading to cardio
vascular disorders; or (2) oral contraceptives may unmask a small
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population predisposed to vascular changes characteristic of
cardiovascular disorders.
Irey and Norris

(1973) conducted a study designed to investi

gate the possibility that the vascular system may be a target
organ for lesions as a result of the use of oral contraceptives.
The authors studied the vasculature of various organs in 16
cadavers.

Seven of the subjects had been using oral contraceptives,

five were pregnant, and four had recently given birth at the time
of death.

The control group consisted of female cadavers who had

either died suddenly or who had been clinically diagnosed as having
cardiovascular disease.

The authors found thickening of the intimai

(innermost) layer of the arteries of several organs in the experi
mental cadavers,

such that lumen size was reduced.

This intimai

thickening was judged to be greater for the experimental group than
for the control group.

It was concluded that although the vascular

lesions could not be directly linked to the use of oral contra
ceptives,

the results indicated that contraceptives may contribute

to the development of cardiovascular disease.
Researchers have attempted to correlate the use of oral
contraceptives w i t h various physiological conditions associated
with cardiovascular disease.

Brakman (Salhanick et a l . , 1969)

conducted a study of 29 subjects using oral contraceptives, and
he found increased fibrinolytic activity in those subjects as
compared to control subjects.

The fibrinolytic enzyme system
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dissolves small deposits of blood clotting elements in blood
vessels; increased levels of these clotting elements produce in
creased activity of the fibrinolytic enzyme system.

Thus it was

concluded that oral contraceptives may increase the level of blood
clotting elements.
Daniel et al.

(Boffa et a l . , 1973) found that women using

oral contraceptives have an elevated level of Factor IX, a clotting
factor found in the blood.

Ygge et al.

(1969) conducted blood

analyses on 15 women who had used oral contraceptives for a
period of one year.

The authors found significant increases in

plasminogen, number of blood platelets, and antifibrinolytic activity.
Peterson et al.

(Boffa et a l . , 1973) conducted a study of 33 women

aged 17-44 years who had taken oral contraceptives for periods
ranging from 2-48 months.

The results of blood analyses indicated

depressed levels of antithrombin III and elevated levels of plas
minogen when compared to control subjects; both of these conditions
are conducive to an increased risk of vascular thrombosis.
Bolton et al.

(1968) found abnormal blood platelet sensi

tivity to adenosine diphosphate

(ADP) in 11 women using oral contra

ceptives as compared to a control group.

The authors noted that

this pattern of abnormal blood platelet sensitivity to ADP is similar
to the pattern exhibited by patients with arterial occlusive dis
ease.

Aronson et al.

(1971) reported a study in which eight of

their 47 experimental subjects using oral contraceptives demonstrated
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elevated blood viscosity as compared to 12 control subjects.

Fisch

and Freedman (1975) reported an increased rate of fibrin formation
and increased blood clot firmness in women using oral contra
ceptives as compared to control subjects.
One of the blood component conditions that has been consis
tently associated with the use of oral contraceptives is an elevated
level of blood lipids,

de Alvarez et al.,

(1973) defined blood

lipids as including fatty acids, neutral fats, phospho-lipids,
cholesterol, and vitamins A, D, E, and K.

Stokes and Wynn (1971)

stated that most forms of hyperlipidemia are associated with the
premature development of occlusive vascular disease,
et al.

de Alvarez

(1973) offered three experimental findings that suggest that

lipids might play a role in vascular pathology:

(1)

esterified

cholesterol is known to accumulate in fibrous plaques in blood
vessels;

(2) atherosclerosis can be experimentally induced in animals

by maintaining them on a high cholesterol diet;

(3) according to the

authors, a study conducted in Framingham and Osle related elevated
lipid levels in apparently healthy people to subsequent coronary
heart disease.
Wynn, Doar, and Mills (1966) studied the blood lipid levels
of 102 women using oral contraceptives and compared them to the
blood lipid levels of 75 control subjects.
included Ovulen, Metrulen,

The contraceptives used

Conovoid, and Anovlar.

Both the exper

imental and the control groups were divided into one group aged
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20-29 years and another group aged 30-39 years.

Significant

differences for serum cholesterol levels were found between the
experimental and control groups aged 20-29 years only.

The serum

triglyceride levels were significantly higher for both age cate
gories in the experimental group as compared to the control group;
31% of the experimental group had serum triglyceride levels above
131mg/100ml, the highest level found for any of the control subjects.
The authors noted that there are both retrospective and
prospective studies that associate elevated serum lipid levels with
the development of atherosclerosis.

They therefore suggested that

the use of oral contraceptives may be a contributing factor to
the development of cardiovascular disease.

A weakness of this

study is that blood lipid levels were not assessed before the use
of oral contraceptives began, making it difficult to directly re
late elevated blood lipids to the use of oral contraceptives.
Brody et al.

(1968) studied the effects of oral contra

ceptives on blood lipid levels of nine women taking Anovlar, nine
women taking Ovulen, and six women using Volidan.

Blood lipid

levels were assessed before administration of the medication, and
again after the first, third, sixth, and twelfth months of use.
The results indicated n o significant changes in serum cholesterol
levels, but triglyceride levels were significantly elevated for
those subjects using Ovulen or Volidan.

The authors noted that

different types and amounts of estrogen and progesterone compounds
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have varying effects on blood lipids.

Their results indicated that

oral contraceptives with predominantly estrogenic activity

(Ovulen

and Volidan) elevate blood lipids, while those contraceptives with
predominantly progesterogenic activity (Anovlar) produce the
opposite results.

The authors concluded that the effects of various

oral contraceptives on blood lipids are dependent on the estrogen
and progesterone dosage levels relative to each other.
Sachs et al.

(1969) investigated the blood lipid levels of

19 women aged 17-42 years who were using Ovulen.

Blood analyses

were performed before the subjects began using the oral contra
ceptive and again at several intervals during the following 18
months.

The results indicated a progressive elevation of tri

glycerides in 16 subjects, so that at the end of the 18 months the
mean triglyceride level was 40mg/100ml above the mean level obtained
before the medication was taken.

This elevation did not, however,

exceed the normal limits of ISOmg/lOOml as defined by the authors.
Phospholipids were also elevated in 12 subjects to a level of
267-276mg/10Qml, and serum cholesterol levels were increased
slightly but not to a significant degree.
Wynn et al.

(1969) studied the blood lipid levels by using

two different approaches:

(A) 116 women were tested before and

during the use of oral contraceptives;

(B) 48 women were tested dur

ing and after discontinuation of the use of oral contraceptives.
The majority of subjects were using either Ovulen or Gynovular.
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The mean duration of use of contraceptives for Group B was 25.4
months.

The authors defined the upper limit of normal triglyceride

levels as 131mg/100ml.

The results indicated that 15 Group A

subjects and 21 Group B subjects demonstrated abnormally elevated
triglyceride levels during the use of the medications.

At least

some elevation of serum triglycerides was found for 111 of 116
subjects in Group A.

The authors stated that while not all women

developed elevated serum triglyceride levels above the normal
limit, it is possible that even small increases in serum lipids
may accelerate the development of atherosclerosis.
Ham and Rose (1969) investigated the response of lipopro
tein lipase to heparin in 19 subjects aged 20-38 years who had
taken oral contraceptives for at least six months.
subjects were using Ovulen,

Eleven of the

three were using Anovlar, and the

other five were each using a different medication.
group consisted of 21 subjects aged 20-35 years.

The control
The results indi

cated that the mean lipoprotein lipase activity was significantly
lower in the experimental group as compared to the control group,
with a mean reduction of 38%.

The lipoprotein lipase activity of

13 of the experimental subjects was lower than the lowest activity
level found for any of the controls.

The authors referred to a

study by Garfinkel et al. that demonstrated a direct relationship of
triglyceride absorption of adipose tissue to the lipoprotein lipase
activity of that tissue.

Thus the elevated blood lipids found by
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many researchers in users of oral contraceptives may be due to a
reduced ability to clear the blood of excess triglycerides via
the lipoprotein lipase activity.
Stokes and Wynn (1971) studied the serum lipid levels in 525
women using estrogen-progesterone combination pills, 35 women
using sequential pills, and 116 control subjects.

The mean serum

triglyceride levels for women using Ovulen or Volidan were 112
mg/100ml and llSmg/lOOml respectively, while the mean serum
triglyceride level for the control group was 68mg/100ml.

Since

Ovulen and Volidan contain the greatest concentrations of estro
gen content of any of the medications used, the authors concluded
that the estrogen content appears to determine the degree of ele
vation of serum triglycerides in users of oral contraceptives.
The authors also noted that the elevated lipid levels found in
users of oral contraceptives resembles the pattern found in patients
diagnosed as having Type IV hyperlipoproteinemia.

They further

noted that several authors have associated that pattern type with
an accelerated development of atherosclerosis.
Schenker et al.

(1972) conducted a study of serum lipids of

375 women aged 19-30 years who were using either combination or
sequential oral contraceptives, and 66 control subjects.
tion of oral contraceptive use ranged from 3 to 37 months.

The dura
The

results indicated significantly higher triglyceride and total serum
lipid levels in the experimental group as compared to the control
group; the mean total serum lipid level for the control group was
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596mg/100ml, while the mean for the experimental group was
722mg/100ml.
Spellacy et al.

(1973) measured the serum lipid levels of

245 women using oral contraceptives, 126 of whom were using Ovulen.
The authors claimed to have two control sources available to them;
(1) the pretreatment serum lipid levels of the experimental group;
(2) 38 control subjects not using oral contraceptives.

Serum

lipid levels were measured six and twelve months after the use of
the medications began.

The results indicated significantly ele

vated serum triglyceride levels for the high estrogen compound
Ovulen as compared to the two control conditions.

There were no

significant differences in triglyceride levels between the six
and twelve month time periods.

The authors suggested that elevated

triglycerides in the extreme may contribute to acute vascular
accidents.
Donde and Virkar (1975) analyzed the serum triglycerides,
free fatty acids, phospholipids, and cholesterol in women aged 19-41
years who were using estrogen-progesterone combination pills.

The

authors excluded from their study those subjects who had a history
of thrombophlebitis, diabetes, hypertension,
disease.

or kidney and heart

The results indicated significantly elevated serum levels

of all four components tested for, although none of the components
were elevated beyond normal limits.

The greatest elevation of serum

triglycerides was demonstrated by those subjects who had been using
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Ovral for 25-36 months.
Conclusions concerning the effects of oral contraceptives on
the vascular system are difficult to make.

The literature con

cerning the effects of oral contraceptives on individual blood
components is plagued by a lack of uniformity in experimental
design, techniques of assessment, and even criteria for normality.
There does seem to be general agreement among various studies that
the use of oral contraceptives, particularly the estrogen-progesterone
combination type, may produce elevated blood serum lipids.
The research concerning the vascular effects of oral contra
ceptives offers several possible mechanisms whereby the auditory
system might be affected.

This is especially true for the effect

of elevated blood lipids, particularly in vi e w of the findings of
Rosen (1964, 1965, 1970a), Spencer (1973), and Cunningham and
Goetzinger (1974).

The possible effects of oral contraceptives on

hearing acuity has been recognized by at least two authors.

Spencer

(1973) cited Levy and Stone in stating that oral contraceptives
may be a secondary cause in the production of a Type IV hyperlipopro
teinemia.

Based on the results of his study cited previously, he

concluded that an audiological examination may aid in the early
detection of hyperlipoproteinemia in patients who are high risks for
developing atherosclerosis.

Shulman (1974) discussed his clinical

impressions of the relationships of hearing loss, tinnitus, vertigo,
alone or in combination, to the use of oral contraceptives.

He

suggested that oral contraceptives be considered as a possible
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etlologlc factor In the diagnosis of hearing loss.

Statement of Purpose
The purpose of this study was to Investigate the relation
ship of the use of oral contraceptives and Extra-High Frequency
(EHF) thresholds In women aged 18-28 years.

More specifically,

experiment was designed to test the following hypotheses:
Ho^:

Women using the estrogen-progesterone combination

oral contraceptives will demonstrate elevated EHF (10-18K Hz)
pure tone thresholds as compared to a control group of women who
have never used oral contraceptives.
HOg:

The elevation of EHF pure tone thresholds will be

greater as the duration of use of the medication Increases.

the

CHAPTER II

PROCEDURE

Subi ects
A total of 42 subjects aged 18-28 years were used in this
study.

The subjects w ere divided into three groups as follows:

(1) Group A consisted of 14 subjects who have been using oral con
traceptives continuously for the last 4 years or more;

(2) Group

B consisted of 14 subjects who have been using oral contraceptives
continuously for the last 1-3 years;

(3) Group C consisted of 14

subjects who have never used oral contraceptives.
The subjects were restricted in age to the years 18-28 in
order to minimize the possible effects of beginning presbycusis;
Rosen (1965) and Drettner et al.

(1975) stated that the onset of

presbycusis can occur as early as the third decade of life.
Smoking is another factor for which subjects were controlled,

Allison

and Roth (1969) listed the following three effects of cigarette
smoking on the vascular system as being generally accepted by
researchers:

(1) constriction of peripheral blood vessels;

increased pulse rate;

(2)

(3) increased systolic and diastolic blood

pressure.

31

32

Diehl (1969) and Constantinides

(197L) discussed the presence

of carbon monoxide in cigarette smoke and the resulting reduced
oxygen-carrying capacity of the blood.

Diehl (1969) stated that

in the average smoker carbon monoxide inactivates 2-6% of the
hemoglobin available, and in the heavy smoker up to 8% is inactivated.
The carbon monoxide has a greater affinity for hemoglobin than does
oxygen, and therefore the blood has a reduced capacity for carrying
oxygen to the cells of the body.

When one considers the discussion

by Fisch (1970) of the auditory system as one of high metabolic
activity and oxygen consumption, particularly at the basal end,
it appears that cigarette smoking could be a contributing factor
in elevated EHF thresholds.

This factor was controlled for by

eliminating those subjects who could be defined as "regular smokers."
A "regular smoker" was operationally defined as a person who smokes
more than 20 cigarettes/week.
All subjects were also required to meet the following cri
teria:

(1) normal middle ear functioning bilaterally as demon

strated by impedance audiometry;

(2) bilateral pure tone thresholds

of lOdB or better for 2K and 4K Hz, and 15dB or better for 6K Hz;
(3)

no reported history of noise exposure;

with blood pressure;
usage;

(4) no reported problems

(5) n o reported history of ototoxic drug

(6) no restrictive dietary programs, such as low cholesterol

or low sugar diets; and (7) no personal history of diabetes.

All

subjects for the 2 experimental groups and the control group were
young women from the University of Montana and the community of
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Missoula who volunteered for the study after being informed of its
purpose by the author directly or by volunteers representing him.

Instrumentation
All audiological testing was conducted in a single-walled
Industrial Acoustics Company (lAC) sound-treated room at the
University of Montana Speech and Hearing Clinic.

Ambient noise

measurements of the sound-treated room were conducted prior to
the experimental testing of subjects, and the levels were found
to be w i thin acceptable limits in reference to ANSI 1969 standards.
Tympanometry for the assessment of middle ear functioning was
accomplished with an American Electromedics Acoustic Impedance
Bridge.

Pure tone testing for the frequencies 2K, 4K, and 6K Hz

was carried out on a Grason-Stadler Bekesy Audiometer (Type E-800)
with the frequencies delivered to the ear v i a TDH-39 earphones.
This testing served to establish normal hearing for the conventional
audiometric frequencies and also provided a practice period for the
patient in operating the Bekesy audiometer.

Extra-High Frequency

audiometry was conducted with a Grason-Stadler

(Type E-800) Bekesy

Audiometer, which utilizes a General Radio Beat Frequency Audio
Generator

(1304-B) as a signal source.

The signal was routed to an

Allison Variable Filter (AL-2B), and then to a McIntosh Power
Amplifier (MG40).

The Extra-High Frequencies were delivered to

the ear via a pair of Koss Pro (4AA) stereophonic earphones.
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Periodic intensity calibration of the Grason-Stadler Bekesy
Audiometer (E-800) for the conventional audiometric frequencies
was carried out with a Bruel and Kjaer

(B and K) Condensor M i c r o 

phone Cartridge (4131), combined with a B and K Artificial Ear
connected to a B and K Sound Level Meter

(2203).

(4152)

Calibration of

the equipment for the Extra-High Frequencies involved the use of a
B and K Artificial Ear

(4152) utilizing a B and K Condensor M i c r o 

phone (4132), in combination with a B and K Audio Frequency Spectro3
meter (2112).
Band

This equipment was also used to obtain a 1/3 Octave

analysis of the signal output from the Koss Pro (4AA) earphones

with input signals centering on the frequencies lOK, 12.5K, 16K, and
20K Hz.

The results obtained with each of the four input signals

listed above indicated decreased output sound pressure levels of
45-50 dB/octave for frequencies above and below the center frequency.
The Koss Pro (4AA) earphones were therefore judged to be adequate
transducers for the purposes of this study.

3

It should be noted that the B & K Artificial Ear (4152)
is designed to be used for calibration of supra-aural earphones
and not for a circumaural earphone such as the Koss Pro (4AA)
(Wilbur, 1972).
The sound pressure levels for the Extra-High fre
quencies obtained with this calibration system are therefore not
necessarily the true sound pressure levels present at the patient *s
eardrum.
However, the calibration procedure used in this study was
not intended to determine the exact sound pressure level at the
eardrum but rather to verify that the earphone output remained con
stant from one test session to the next.
The calibration system
described above was considered to be adequate for its intended
purpose.
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Procedure
Case history information, impedance results, and pure tone
test results for the conventional audiometric frequencies were
obtained before EHF testing began.

Because of differences in the

shape and size of the external auditory meatus among subjects, ear
phone placement for each EHF was achieved by a "best fit" method,
whereby the subject varied the earphone position until a constant
suprathreshold tone sounded the loudest.

This "best fit" method

was used by each subject for each ear at each of the 5 Extra-High
Frequencies tested.

Pulsed tone, fixed frequency Bekesy tracings

were obtained for the frequencies lOK, 12K, 14K, 16K, and 18K Hz,
bilaterally.

The order of ear presentation was alternated for each

successive subject in each of the three groups.

The tracings for

each frequency were carried out for one minute, and the midpoint
of the upward and downward movement of the pen closest to the 45th
second was recorded as the threshold for that frequency.

This

procedure was adopted in an attempt to replicate as closely as
possible the procedure used in a previous study

(Cunningham and

Goetzinger, 19 74).
A mean EHF hearing threshold level for each ear at each of
the five frequencies tested was calculated for each of the 3 sub
ject groups.

A Lindquist Type I, repeated measures analysis of

variance was used to evaluate the test results for each of the
five Extra-High Frequencies.

CHAPTER III

RESULTS

The two major hypotheses of this study were as follows:
Ho^:

Women using the estrogen progesterone
combination oral contraceptives will
demonstrate elevated EHF (10K-18K Hz)
pure tone thresholds as compared to a
control group of women who have never
used oral contraceptives;

HOg:

The elevation of EHF pure tone thresholds
will be greater as the duration of use of
oral contraceptives increases.

The data used in this study consisted of pure tone thres
holds for both ears of each subject for the frequencies lOK, 12K,
14 k , 16K, and 18K Hz.

The mean and standard deviation for age

for each of the three subject groups is listed in Table 1.
raw data used for
Appendix A.

the

The

statistical analyses are presented in

Table 2 presents the mean raw score and standard

deviation for each group with frequency, ear tested, and duration
of use of oral contraceptives considered.

The results were

analyzed using a Lindquist Type I "repeated measures" analysis of
variance for each of the 5 Extra-High Frequencies tested.

A summary

of the analysis of variance for each of the five Extra-High Fre
quencies tested is presented in Tables 3^-3^.

Table 4 presents

the results comparing the variance of each subject group with the
variance of the other two subject groups for each ear at each of
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TABLE 1

GROUP MEANS AND STANDARD DEVIATIONS FOR AGE

GROUP

Mean

Standard Deviation

Group A (4+ years on
oral contraceptives)

22.85 years

1.46

Group B (1-3 years on
oral contraceptives)

22.79 years

2.33

Group C (0 years on
oral contraceptives)

22.42 years

2.50

TABLE 2
M EAN AND STANDARD DEVIATIONS FOR EHF HEARING THRESHOLD (dB SPL) BY FREQUENCY,
EAR TESTED, AND DURATION OF USE OF ORAL CONTRACEPTIVES

RIGHT EAR

0 years

1-3 years

4+ years

Total

(All Subjects)

F

Mean

S.D.

Mean

S.D.

Mean

S.D.

Mean

S.D.

lOK
12K
14K
16K
18K

29.57
45.50
47.00
61.07
82.29

5.04
10.64
10.77
17.32
13.68

27.14
42.21
40.36
53.21
76.50

5.18
7.03
12.12
18.26
17.74

30.50
38.50
43.07
59.21
79.93

9.49
11.22
11.38
20.49
15.06

29.07
42.07
43.48
57.83
79.57

7.04
10.22
11.74
19.05
15.78

LEFT EAR
0 years

1-3 years

F

Mean

S.D.

Mean

lOK
12K
14K
16K
18K

29.29
41.86
44.14
61.57
86.00

4.15
9.75
16.08
20.89
14.78

26.29
39.64
39.71
58.00
79.43

■ S.D.
8.38
12.10
14.68
21.06
17.36

4+ years

Total (All Subjects)

Mean

S.D.

Mean

S.D.

30.07
40.64
47.07
61.79
80.64

6.06
16.11
12.81
19.24
19.49

28.55
40.71
43.64
60.45
82.02

6.63
12.97
16.61
28.79
26.49

w
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TABLE 3.
A

SUMMARY OF ANALYSIS OF VARIANCE
OF EHF THRESHOLDS AT lOK Hz

SOURCE

Sums of
Squares

Degrees of Mean
Freedom
Squares

TOTAL

3932.95

83

BETWEEN SUBJECTS

3057,95

41

194.67

2

97.33

2863.28

39

73.42

875.00

42

Ear tested

5.76

1

Ear tested x duration

1.24
868.00

Duration of use
Error^

WITHIN SUBJECTS

Error

w

F .05, df 2/39 = 3.24
F .03, df 1/39 = 4.09

F
Ratio

P

1.33

NS

5.76

<1.00

NS

2

.62

<1.00

NS

39

22.26

40

TABLE 3

B

SUMMARY OF ANALYSIS OF VARIANCE
OF EHF THRESHOLDS AT 12K Hz

SOURCE

TOTAL

BETWEEN SUBJECTS
Duration of use
Error^

WITHIN SUBJECTS
Ear tested
Ear tested x duration
Error^

F .05, df 2/39 = 3.24
F .05, df 1/39 = 4.09

Sums of
Squares

Degrees of
Freedom

Mean
Squares

11470.00

83

4612.54

41

245.22

2

122.61

4367.32

39

111.98

6857.46

42

38.68

1

132.64
6686.14

F
Ratio

P

1.09

NS

38.68

<1.00

NS

2

66.32

<1.00

NS

39

171.45

41

TABLE

SUMMARY OF ANALYSIS OF VARIANCE
OF EHF THRESHOLDS AT 14K Hz

SOURCE

Sums of
Squares

Degrees of
Freedom

Mean
Squares

F
Ratio

P

<1.00

NS

TOTAL

15122.70

83

BETWEEN SUBJECTS

11288.20

41

525.02

2

265.51

10763.18

39

275.98

3834.50

42

.58

1

.58

<1.00

NS

171.46

2

85.73

<1.00

NS

3662.46

39

93.91

Duration of use
Error^^

WITHIN SUBJECTS
Ear tested
Ear tested x duration
Error

w

F .05, df 2/39 = 3.24
F .05, df 1/39 = 4.09

42

TABLE 3p

SUMMARY OF ANALYSIS OF VARIANCE
OF EHF THRESHOLDS AT 16K Hz

Sums of
Squares

Degrees of
Freedom

TOTAL

32996.29

83

BETWEEN SUBJECTS

29959.29

41

534.50

SOURCE

Duration of use
Errorj^

WITHIN SUBJECTS
Ear tested
Ear tested x duration
Error

w

F .05, df 2/39 = 3.24

F .05, df 1/39 = 4.09

Mean
Squares

F
Ratio

P

2

267.25

<1.00

NS

29424.79

39

754.48

3037.00

42

144.05

1

144.05

1.99

NS

64.31

2

32.16

<1.00

NS

2828.64

39

72.53
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TABLE 3_
£i

SUMMARY OF ANALYSIS OF VARIANCE
OF EHF THRESHOLDS AT 18K Hz

SOURCE

Sums of
Squares

Degrees of
Freedom

Mean
Squares

F
Ratio

P

<1.00

NS

TOTAL

23507.56

83

BETWEEN SUBJECTS

20378.06

41

545.45

2

272.73

19832.61

39

508.53

3129.50

42

126.29

1

126.29

1.66

NS

33.89

2

16.95

<1.00

NS

2969.32

39

76.14

Duration of use
Error^^

WITHIN SUBJECTS
Ear tested
Ear tested x duration
Error

w

F .05, df 2/39 = 3.24

F .05, df 1/39 = 4.09
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TABLE 4

SUMMARY OF F-TESTS COMPARING GROUP VARIANCES
BY EAR TESTED AND FREQUENCY

RIGHT EAR

Comparisons

lOK

12K

14K

16K

18K

Group A with Group B

3.36

2.54

1.13

1.26

1.39

Group A with Group C

3.56

1.11

1.12

1.40

1.21

Group B with Group C

1.05

2.29

1.27

1.11

1.68

LEFT ]EAR

Comparisons

lOK

12K

14K

16K

18K

Group A with Group B

1.91

1.77

1.31

1.20

1.26

Group A w i t h Group C

2.13

2.73

1.58

1.18

1.74

Group B with Group C

4.08

1.54

1.20

1.02

1.38

F .05, df 13/13 = 2.58
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the five frequencies tested.

A confidence level o f . 05 was used

for all tests of significance.
The results of the analyses of variance indicate that the
EHF pure tone thresholds of women using oral contraceptives were
not significantly different from those of women who have never
used oral contraceptives at any of the five frequencies tested.
The results also indicate that there were no significant differ
ences between right and left ear thresholds for subjects at any
of the five Extra-High Frequencies.

Finally, the interaction of

duration of use of oral contraceptives by ear tested was not
statistically significant.

The results of all F tests computed

in Tables 3^-3^ were not statistically significant even at the
.10 level of confidence.
The major factors under consideration in this study included:
(1) duration of use of oral contraceptives (0 years, 1-3 years, and
4+ years);

and

(2) right versus left ears.

When a non-statistical

comparison of the mean EHF hearing thresholds of the two groups
of oral contraceptive users was made for each ear at each of the
five frequencies tested, it was discovered that the group of sub
jects who have used oral contraceptives for four or more years had
higher m e a n hearing thresholds than the subjects who have used oral
contraceptives for 1-3 years in nine out of the ten possible compari
sons.

However, when comparing the mean EHF thresholds of the sub

jects using oral contraceptives with the control group for each ear
at each frequency tested, no such consistent pattern emerges.
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The results of the 30 F-tests comparing the variance of
each subject group with the variance of the other two subject
groups for each ear at each of the five frequencies tested indicate
that only 4 of the possible 30 F-ratios computed were statistically
significant.

CHAPTER IV

DISCUSSION

The purpose of this study was to investigate the possible
effects of oral contraceptives on Extra-High Frequency
tone thresholds.

(EHF) pure

The literature concerning the effects of oral

contraceptives on the vascular system contains several studies
which have demonstrated that blood serum lipids and certain blood
clotting components are significantly elevated in women who use
oral contraceptives.

Other studies have demonstrated elevated EHF

pure tone thresholds in subjects with clinically diagnosed ele
vated blood lipids as compared to control groups

(Rosen and Clin,

1965; Rosen et al., 1970a; Cunningham and Goetzinger, 1974).

This

author therefore hypothesized that if significant blood chemistry
changes such as elevated blood lipids and other clotting factors
occur in women who use oral contraceptives, such changes may be
manifested in elevated EHF thresholds as compared to the EHF
thresholds of women who have never used oral contraceptives.
The results of this study indicate no significant differ
ences in EHF pure tone thresholds between a group of women using
oral contraceptives and a control group at any of the five EHFs
tested.

These findings are not in agreement with those reported

in previous investigations of EHF hearing acuity in subjects demon47
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strating elevated blood lipids (Rosen arid Olin, 1965; Rosen et al.,
1970; Cunningham and Goetzinger,

1974).

However,

there are several

differences between this study and previous studies that alone, or
in combination, may account for the differences in the results.
Some of the major differences between this study and those
done previously involve the criteria used for subject selection.
For example, the subjects for this study were required to have
bilateral pure tone thresholds of lOdB or better at 2K and 4K Hz,
and 15dB or better at 6K Hz.

In the Cunningham and Goetzinger

(1974) study concerning the relationship of EHF hearing acuity
and elevated blood lipids, subjects were required only to have
bilateral pure tone thresholds of 20dB at IK and 2K Hz, and 35dB
at 4K and 6K Hz.

The conclusion of their study was that elevated

EHF thresholds were significantly related to elevated blood lipid
levels.

However, the above criteria may have allowed for selection

as subjects some people with minimal high frequency hearing loss
due to factors such as heredity, illness, high fevers, etc.

If

such was the case, it would be difficult to determine whether the
elevated EHF thresholds found in their experimental subjects were
related to abnormally elevated blood lipids or to some other fac
tor leading to high frequency hearing loss.
by Rosen (1964, 1965,

The studies conducted

1970a) reported no specific criteria for sub

ject hearing acuity at the conventional audiometric frequencies,
and they also did not appear to control their selection of subjects
for factors that might contribute to EHF hearing loss.
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Another difference between this study and that conducted by
Cunningham and Goetzinger
age of the subjects.

(1974) is the criterion restricting the

The age criterion for this study required

that subjects be between 18 and 28 years of age.

The Cunningham

and Goetzinger study, on the other hand, required only that sub
jects be between 20 and 50 years of age.

An age criterion of such

wide range could allow for an age distribution between and within
groups such that the differences found in EHF thresholds might be
due to sampling error only.

Rosen (1964) and Drettner et al (1975)

stated that the onset of presbycusis can occur as early as the third
decade of life.

If such is the case, the age criterion of the

Cunningham and Goetzinger (1974) study does not appear to be re
strictive enough to eliminate presbycusis as a possible factor
influencing their findings.

Thus the elevated EHF thresholds

found in the experimental group as compared to a control group may
be due at least in part to possible age differences between experi
mental and control subjects.
The differences in results between this study and those
conducted by Rosen et al.

(1964, 1965, 1970a) and Cunningham and

Goetzinger (1974) may b e due to the stricter control in subject
selection for age and hearing acuity for conventional audiometric
frequencies used in the current study.

However,

this study also

differs from previous investigations using EHFs in terms of the
method used for delivering the acoustic signal to the ear.

The
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experimental procedure for this study involved the use of earphones
for delivery of the EHFs to the ear.

Earphone placement for each

EHF was achieved by a "best fit" method, whereby the subject varied
the earphone position until a constant suprathreshold EHF pure tone
sounded the loudest.

Every subject carried out this procedure on

each ear for each of the five frequencies tested.

The technique

used for signal delivery to the ear in previous studies of EHFs
involved the use of a probe tube that inserts into the ear canal
in place of conventional earphones
et a l . , 1968).

(Rosen et al., 1964; Vassalo

The probe tube assembly allows the experimenter

to place the signal source at a relatively constant distance from
the tympanic membrane for all subjects.
Some authors have suggested that the use of earphones for
delivery of EHFs is unsatisfactory due to individual differences
in ear canal size and shape and the cavity size interaction with
the wavelength of the signals (Rosen et al.,

1964).

An attempt

was made in this study to control for these individual differences
by use of the "best fit" technique of earphone placement for each
EHF as described previously.

The results of 30 F-tests comparing

the variance of each subject group with the variance of the other
two subject groups for each ear at each of the five frequencies
tested indicate that only four of the 30 F-ratios computed were
statistically significant.

Thus,

in only a minor number of cases

did the variance of one subject group differ significantly from
the variances of either of the other two subject groups.

These
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findings suggest that the use of earphones with a "best fit" method
for placement is an appropriate technique for this study.

Although

the use of a probe tube assembly rather than earphones may have
yielded more precise EHF thresholds, it does not appear to be a
crucial factor in this study which compared results between matched
control and experimental groups.
A nonstatistical observation of the mean thresholds of the
three subject groups for each ear at each of the five frequencies
tested provides an interesting finding in this study.
the control group,

Disregarding

the group of subjects who have used oral con

traceptives for the last four or more years demonstrated higher
mean thresholds than the group of subjects who have used oral
contraceptives for the last one to three years in nine out of the
ten possible comparisons.

The consistency of the higher mean

EHF thresholds for the "long term"

(4 or more years) oral contra

ceptive users as compared to the "short term"

(1-3 years) oral

contraceptive users across frequencies and ears may be an indi
cation of some effect of duration of oral contraceptive use on the
auditory system.

H o w e v e r , the mean EHF thresholds of the control

group are higher than those of the "long term" oral contraceptive
users in six out of ten possible comparisons, and are higher
than those of the "short term" oral contraceptive users in all
ten possible comparisons.
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The results of this study indicate that women who use oral
contraceptives did not have significantly different EHF pure tone
thresholds than w omen who have never used oral contraceptives.
These findings suggest that oral contraceptives do not elevate as a
group the blood lipids and various other blood clotting elements
sufficiently to affect the EHF hearing acuity.

Recommendations for Further Research
The results of this study indicate that women, as a group,
who use oral contraceptives did not demonstrate significantly
elevated EHF pure tone thresholds as compared to the EHF thresholds
of women who have never used oral contraceptives.

However,

further

investigation of the relationship of EHF thresholds to the use of
oral contraceptives utilizing different experimental procedures
may be productive.

Listed below are some suggestions for further

investigation of this subject.
1.

It may be useful to investigate the EHF thresholds of a

select group of subjects who demonstrate various side effects from
use of oral contraceptives.

Fletcher and Alkjaersig (Salhanick et

a l . , 1969) hypothesized that oral contraceptives may induce cer
tain blood chemistry changes in a minority of users who may be
predisposed to such alterations.

Perhaps those individuals who

suffer various side effects from oral contraceptives are also sus
ceptible to certain blood chemistry changes which in turn may affect
EHF hearing acuity.
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2.

If significantly elevated EHF thresholds are found in a

select group of subjects such as those discussed above, it might
be useful to investigate whether or not the factor of smoking has
any additional effect on EHF thresholds.
Drettner et al.

A study conducted by

(1975) indicates that there may be a relationship

between smoking and hearing acuity.

One could design a study in

which the EHF thresholds of women who demonstrate a number of side
effects from the use of oral contraceptives and who also smoke are
compared with the EHF thresholds of another select group of oral
contraceptive users who do not smoke.
3.

If significantly elevated EHF thresholds as compared to

those of a control group are found in a select subject group such
as the one discussed above, it would be of value to conduct blood
analyses on all subjects in order to determine whether or not the
EHF thresholds are directly related to the levels of serum lipids
and other blood clotting components.

CHAPTER V

SUMMARY A N D CONCLUSIONS

This study was undertaken to investigate the possible rela
tionship of Extra-High Frequency
use of oral contraceptives.

(EHF) pure tone thresholds to the

The major hypothesis of the project was

that women using oral contraceptives would demonstrate significantly
higher thresholds for the EHFs than women who have never used oral
contraceptives.

The procedure involved the determination of aud

itory thresholds of 42 subjects for the frequencies lOK, 12K, 14K,
16K, and 18K Hz using automatic audiometry.
divided into three groups as f ollows :

The subjects were

(1) 14 wo m e n aged 18-28

years who have used oral contraceptives continuously for the last
four or more years;

(2) 14 women aged 18-28 years who have used oral

contraceptives continuously for the last one-three years;

(3) 14

women aged 18-28 years w h o have never used oral contraceptives.
All subjects reported no history of excessive noise exposure and
were

required to pass a pure tone screening test bilaterally for

the frequencies 2K, 4K, and 6K Hz.
trolled for (a) smoking,

In addition, subjects were con

(b) medically restrictive diets such as

low cholesterol or low sugar,

(c) reported elevated blood pressure,

and (d) ototoxic drug usage.
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The results of the study Indicated no significant differ
ences in EHF pure tone thresholds between subjects using oral con
traceptives and control subjects for any of the five Extra-High
frequencies tested.

There was a general but statistically non

significant trend for the group of women using oral contraceptives
for the last four or more years to have higher m e a n EHF thresholds
than the group of women using oral contraceptives for the last
one-three years; however, neither group of oral contraceptive users
demonstrated consistently higher EHF thresholds than the control
group.

The differences in results between this study and previous

investigations of the relationship of EHF thresholds to elevated
blood lipids and various blood clotting components were discussed
in terms of the differences in subject selection and experimental
procedures.

It was concluded that the use of oral contraceptives

does not appear to significantly affect, as a group, the EHF hearing
acuity of normal women aged 18-28 years.
cerning

Suggestions were made con

possible future investigations of the relationship of EHF

thresholds to the use of oral contraceptives.
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INDIVIDUAL EHF THRESHOLDS

(dB SPL) OF

WOMEN USING ORAL CONTRACEPTIVES FOR 4 OR MORE YEARS
(GROUP A ) ^

RIGHT EAR

s//

LEFT EAR

lOK

12K

14K

16K

18K

lOK

12K

14K

16K

18K

1.

25

36

43

60

85

20

41

34

63

85

2.

14

35

31

46

65

24

21

41

63

67

3.

23

49

45

72

78

22

28

54

57

94

4.

26

15

33

25

54

33

57

55

41

73

5.

25

20

31

62

77

22

29

44

52

76

6.

25

45

52

71

88

31

34

56

82

90

7.

30

51

29

34

59

32

24

60

63

58

8.

34

41

55

115

120

31

30

38

111

120

9.

33

39

57

60

78

29

51

44

28

53

10.

36

39

38

66

85

29

38

34

52

65

11.

32

53

38

43

76

37

32

38

51

54

12.

34

24

31

49

81

39

48

52

67

95

13.

32

45

64

59

86

32

52

48

85

90

14.

58

47

56

67

87

40

84

81

80

108

4
The .reader is reifiin'ded that the actual threshold sound pressure
levels present at the eardrums of the subjects will differ from the
sound pressure levels listed in this Appendix due to certain ex
perimental procedures.
However, since this study involved a
comparison of threshold sound pressure levels of two experimental
groups w i t h thresholds of a control group, and exactly the same test
procedure was used for all 3 subject groups, the accuracy of these
sound pressure level measurements is judged to be sufficient for
purposes of this study.
(See also the footnote on page 34 and dis
cussion on page 50.)
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INDIVIDUAL EHF THRESHOLDS (dB SPL) OF
WOMEN USING ORAL CONTRACEPTIVES FOR 1-3 YEARS
(GROUP B)

RIGHT EAR

LEFT EAR

lOK

12K

14K

16K

18K

lOK

12K

14K

16K

18K

1.

24

47

60

74

83

30

49

58

83

87

2.

26

39

41

68

85

31

48

47

77

97

3.

25

31

60

55

71

20

41

30

64

92

4.

30

35

32

46

48

25

45

37

59

60

5.

31

35

53

99

120

32

52

73

108

109

6.

22

36

25

28

65

13

31

33

34

67

7.

18

36

18

41

59

11

14

22

24

51

8.

31

48

46

30

76

38

38

32

37

103

9.

25

45

32

41

69

25

45

29

52

65

10.

23

42

35

58

72

27

36

30

70

76

11.

34

46

52

55

70

43

65

64

55

63

12.

30

43

37

50

61

22

33

26

43

65

13.

23

51

40

63

97

29

26

36

58

94

14.

38

57

34

37

95

22

32

39

48

83
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INDIVIDUAL EHF THRESHOLDS (dB SPL) OF
WOMEN WHO HAVE NEVER USED ORAL CONTRACEPTIVES
(GROUP C)

LEFT EAR

RIGHT EAR
s#

lOK

12K

14K

16K

18K

lOK

12K

14K

16K

18K

1.

20

25

52

68

87

31

56

47

74

95

2.

38

52

68

88

104

31

26

68

99

98

3.

32

40

38

64

98

34

43

44

87

107

4.

24

26

42

29

74

25

40

21

44

82

5.

34

64

51

80

82

27

36

31

63

78

6.

33

41

39

48

88

34

50

42

45

91

7.

22

47

38

46

74

25

36

32

37

83

8.

30

57

55

47

57

24

35

39

43

69

9.

34

52

33

50

88

30

33

32

49

84

10.

31

43

67

81

108

34

57

60

81

105

11.

26

53

44

56

73

21

34

41

49

75

12.

26

54

33

51

73

28

44

38

47

77

13.

34

43

46

58

69

33

37

38

47

54

14.

30

40

52

89

77

33

59

85

97

106

